forxiga
astrazeneca ab - dapagliflozin propandiol monohidrat - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - zdravila, ki se uporabljajo pri diabetesu - type 2 diabetes mellitusforxiga is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. poleg drugimi zdravili za zdravljenje diabetesa tipa 2. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 in 5. heart failureforxiga is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseforxiga is indicated in adults for the treatment of chronic kidney disease.
oyavas
stada arzneimittel ag - bevacizumab - colorectal neoplasms; breast neoplasms; ovarian neoplasms; fallopian tube neoplasms; peritoneal neoplasms; carcinoma, non-small-cell lung; carcinoma, renal cell; uterine cervical neoplasms - antineoplastična sredstva - oyavas in combination with fluoropyrimidine based chemotherapy is indicated for treatment of adult patients with metastatic carcinoma of the colon or rectum. oyavas in combination with paclitaxel is indicated for first line treatment of adult patients with metastatic breast cancer. za nadaljnje informacije o statusu receptorja človeškega epidermičnega rastnega faktorja 2 (her2) glejte poglavje 5. oyavas in combination with capecitabine is indicated for first line treatment of adult patients with metastatic breast cancer in whom treatment with other chemotherapy options including taxanes or anthracyclines is not considered appropriate. patients who have received taxane and anthracycline containing regimens in the adjuvant setting within the last 12 months should be excluded from treatment with oyavas in combination with capecitabine. za nadaljnje informacije o statusu her2 glejte poglavje 5. oyavas, in addition to platinum based chemotherapy, is indicated for first line treatment of adult patients with unresectable advanced, metastatic or recurrent non small cell lung cancer other than predominantly squamous cell histology. oyavas, in combination with erlotinib, is indicated for first line treatment of adult patients with unresectable advanced, metastatic or recurrent non squamous non small cell lung cancer with epidermal growth factor receptor (egfr) activating mutations (see section 5. oyavas in combination with interferon alfa 2a is indicated for first line treatment of adult patients with advanced and/or metastatic renal cell cancer. oyavas, in combination with carboplatin and paclitaxel is indicated for the front line treatment of adult patients with advanced (international federation of gynecology and obstetrics (figo) stages iii b, iii c and iv) epithelial ovarian, fallopian tube, or primary peritoneal cancer (see section 5. oyavas, in combination with carboplatin and gemcitabine or in combination with carboplatin and paclitaxel, is indicated for treatment of adult patients with first recurrence of platinum sensitive epithelial ovarian, fallopian tube or primary peritoneal cancer who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor–targeted agents. oyavas, in combination with topotecan, or pegylated liposomal doxorubicin is indicated for the treatment of adult patients with platinum resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than two prior chemotherapy regimens and who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor targeted agents (see section 5. oyavas, in combination with paclitaxel and cisplatin or, alternatively, paclitaxel and topotecan in patients who cannot receive platinum therapy, is indicated for the treatment of adult patients with persistent, recurrent, or metastatic carcinoma of the cervix (see section 5.
ibandronska kislina stada 6 mg koncentrat za raztopino za infundiranje
stada arzneimittel ag - ibandronska kislina - koncentrat za raztopino za infundiranje - ibandronska kislina 6 mg / 1 viala - ibandronska kislina
magnevist 0,5 mmol/ml raztopina za injiciranje v napolnjeni injekcijski brizgi
bayer pharma ag - gadopentetna kislina - raztopina za injiciranje - gadopentetna kislina 274 mg / 1 ml - gadopentetna kislina
magnevist 0,5 mmol/ml raztopina za injiciranje v steklenici
bayer pharma ag - gadopentetna kislina - raztopina za injiciranje - gadopentetna kislina 274 mg / 1 ml - gadopentetna kislina
magnevist 0,5 mmol/ml raztopina za injiciranje v viali
bayer pharma ag - gadopentetna kislina - raztopina za injiciranje - gadopentetna kislina 274 mg / 1 ml - gadopentetna kislina
amlodipin/valsartan stada 10 mg/160 mg filmsko obložene tablete
stada arzneimittel ag - amlodipin, valsartan - filmsko obložena tableta - amlodipin 10 mg / 1 tableta; valsartan 160 mg / 1 tableta - valsartan in amlodipin
cinakalcet helm 60 mg filmsko obložene tablete
helm ag - cinakalcet - filmsko obložena tableta - cinakalcet 60 mg / 1 tableta - cinakalcet
stivarga
bayer pharma ag - regorafenib - kolorektalne neoplazme - antineoplastic agents, protein kinase inhibitors - stivarga je označen kot monotherapy za zdravljenje odraslih bolnikov z:metastatskega kolorektalnega raka (crc), ki so bili predhodno zdravljeni z, ali se ne štejejo kandidati, ki so na voljo terapije - ti vključujejo fluoropyrimidine temeljijo na kemoterapijo, anti-vegf terapije in anti-egfr terapije;unresectable ali metastatskim gastrointestinal stromal tumorjev (bistvo), ki je napredoval na ali so nestrpni, da se pred zdravljenjem z imatinib in sunitinib;hepatocellular carcinoma (hcc), ki so bili predhodno zdravljeni z sorafenib.
nutriflex omega special 56/144 emulzija za infundiranje
b. braun melsungen ag - cinkov acetat dihidrat; glicin; glukoza, brezvodna; glutaminska kislina; histidin; kalcijev klorid dihidrat; kalijev acetat; alanin; arginin; asparaginska kislina; fenilalanin; izolevcin; levcin; lizin; metionin; prolin; serin; treonin; triptofan; valin; magnezijev acetat tetrahidrat; natrijev acetat trihidrat; natrijev dihidrogenfosfat dihidrat; natrijev hidroksid; sojino olje, rafinirano; trigliceridi omega-3-kislin; trigliceridi, srednjeverižni, nasičeni; natrijev klorid - emulzija za infundiranje - cinkov acetat dihidrat 7,024 mg / 1 vreča glicin2,312 mg / 1 vreča glukoza, brezvodna144 mg / 1 vreča glutaminska kislina4,908 mg / 1 vreča histidin1,753 mg / 1 vreča kalcijev klorid dihidrat0,623 mg / 1 vreča kalijev acetat3,689 mg / 1 vreča alanin6,792 mg / 1 vreča arginin3,78 mg / 1 vreča asparaginska kislina2,1 mg / 1 vreča fenilalanin4,916 mg / 1 vreča izolevcin3,284 mg / 1 vreča levcin4,384 mg / 1 vreča lizin3,186 mg / 1 vreča metionin2,736 mg / 1 vreča prolin4,76 mg / 1 vreča serin4,2 mg / 1 vreča treonin2,54 mg / 1 vreča triptofan0,8 mg / 1 vreča valin3,604 mg / 1 vreča magnezijev acetat tetrahidrat0,91 mg / 1 vreča natrijev acetat trihidrat0,25 mg / 1 vreča natrijev dihidrogenfosfat dihidrat2,496 mg / 1 vreča natrijev hidroksid1,171 mg / 1 vreča sojino olje, rafinirano16 mg / 1 vreča trigliceridi omega-3-kislin4 mg / 1 vreča trigliceridi, srednjeverižni, nasičeni20 mg / 1 vreča natrijev klorid0,378 mg / 1 vreča; glicin 2,312 mg / 1 vreča glukoza, brezvodna144 mg / 1 vreča glutaminska kislina4,908 mg / 1 vreča histidin1,753 mg / 1 vreča kalcijev klorid dihidrat0,623 mg / 1 vreča kalijev acetat3,689 mg / 1 vreča alanin6,792 mg / 1 vreča arginin3,78 mg / 1 vreča asparaginska kislina2,1 mg / 1 vreča fenilalanin4,916 mg / 1 vreča izolevcin3,284 mg / 1 vreča levcin4,384 mg / 1 vreča lizin3,186 mg / 1 vreča metionin2,736 mg / 1 vreča prolin4,76 mg / 1 vreča serin4,2 mg / 1 vreča treonin2,54 mg / 1 vreča triptofan0,8 mg / 1 vreča valin3,604 mg / 1 vreča magnezijev acetat tetrahidrat0,91 mg / 1 vreča natrijev acetat trihidrat0,25 mg / 1 vreča natrijev dihidrogenfosfat dihidrat2,496 mg / 1 vreča natrijev hidroksid1,171 mg / 1 vreča sojino olje, rafinirano16 mg / 1 vreč - kombinacije